As recombinant human BMP-2 is studied for its role in treatment of RCC [6], it is important to characterize heterotrophic bone formation in all forms of RCC, including MTSCC, and to relate it to the prognosis of patients with RCC. The gene discussed is BMP2; the disease is renal cell carcinoma.